$70.56
0.30.42%
At close: -
Comments
Loading...
Number of Stock Holdings
30
Number of Bond Holdings
-
Total Holdings
33
Number of ETFs
-
Invesco Biotechnology & Genome ETF (ARCA:PBE), Top Holdings
Invesco Biotechnology & Genome ETF (ARCA: PBE)
| Ticker | Name | Share % | |
|---|---|---|---|
| GILD | Gilead Sciences Inc | 5.48% | |
| ILMN | Illumina Inc - Common | 5.37% | |
| INCY | Incyte Corp. | 5.32% | |
| BMRN | Biomarin Pharmaceutical Inc. | 5.09% | |
| VRTX | Vertex Pharmaceuticals Inc | 5.05% | |
| AMGN | Amgen Inc. | 4.98% | |
| REGN | Regeneron Pharmaceuticals, Inc. | 4.97% | |
| NBIX | Neurocrine Biosciences Inc | 4.51% | |
| IONS | Ionis Pharmaceuticals Inc | 3.24% | |
| HALO | Halozyme Therapeutics Inc | 3.17% | |
FAQ
How has PBE ETF performed?
Quote.FAQ.Answers.ETFs.etf-performance
What is the expense ratio for PBE?
Quote.FAQ.Answers.ETFs.expense-ratio
What is the Assets Under Management (AUM) for PBE?
Quote.FAQ.Answers.ETFs.aum
What is the investment style for PBE?
PBE follows a Mid Cap Growth investment style.
What are the top holdings for PBE?
The top holdings of PBE include: GILD (5.48%), ILMN (5.37%), INCY (5.32%), BMRN (5.09%), VRTX (5.05%). These represent the largest positions in the ETF's portfolio.
What is the average daily trading volume for PBE?
Average daily volume data for PBE is currently not available.